Faraz Yousuf
Eli Lilly and Company →
Eli Lilly and Company is a global pharmaceutical manufacturer headquartered in Indianapolis, Indiana, whose recent growth is dominated by GLP-1 injectables (Mounjaro, Zepbound) and other sterile parenteral products. Its manufacturing footprint is expanding aggressively: Lilly has charted roughly $50B in manufacturing investments since 2020, including a $2B+ injectables and device-assembly campus in Concord, North Carolina. The relevant factory-floor work for AGD is sterile injectables fill-finish (filling, stoppering, 100% visual inspection of vials/prefilled syringes/cartridges) and downstream drug-delivery device assembly (assembling prefilled syringes into autoinjectors and pens). The company is investing in robotics, AI-driven process control, and aseptic automation both internally (a Global Robotics Program, dedicated Visual Inspection & Robotics Engineering groups) and via the Purdue/Lilly/Merck Young Institute Pharmaceutical Manufacturing Consortium.
Intelligence
No first-party intel yet
Sources
- Faraz Yousuf - Robotics Application Engineer, Eli Lilly (LinkedIn)
- Eli Lilly scales global manufacturing with learn once, deploy everywhere approach - Pharma Manufacturing
- Automation, robots and local talent guide the way at Lilly's new $2B-plus North Carolina injectables plant - Fierce Pharma
- Digital Transformation at Lilly Manufacturing - Pharmaceutical Technology
- Eli Lilly, Merck, Purdue University team to push innovation in sterile injectables - Pharma Manufacturing
- Lilly Deploys World's Largest AI Factory Using NVIDIA Blackwell - NVIDIA Blog
- How Eli Lilly Does In-Line Medical Device Inspection - Automation World
- Process Automation Engineer @ Eli Lilly - NCBiotech Job Board